![Carol Odle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Carol Odle worked at La Jolla Pharmaceutical Co. from 2014 to 2020, serving as Director-Clinical Projects & Manager in 2020.
Ms. Odle worked at Revelation Biosciences, Inc. as Vice President-Clinical Operations from 2020 to 2022 and again from 2023 to 2026.
Former positions of Carol Odle
| Companies | Position | End |
|---|---|---|
| REVELATION BIOSCIENCES, INC. | Chief Operating Officer | 2026-01-31 |
| REVELATION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-06-30 |
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 2020-07-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Revelation Biosciences, Inc.
 Revelation Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics and diagnostics for viral infections | Health Technology |
- Stock Market
- Insiders
- Carol Odle
Choose MarketScreener 
